| Yang Yang,Lilin He. Immunotherapy induced hypothyroidism with hyperlipidemia: a case report and literature review. Oncol Transl Med, 2022, 8: 100-103. |
| Immunotherapy induced hypothyroidism with hyperlipidemia: a case report and literature review |
| Received:March 29, 2022 Revised:April 29, 2022 |
| View Full Text View/Add Comment Download reader |
| KeyWord:immune-related adverse effects (irAEs); hyperlipidemia; hypothyroidism; immune checkpoint; inhibitors (ICIs); sintilimab; immunotherapy |
| Author Name | Affiliation | E-mail | | Yang Yang | First People''''s Hospital of Tianmen,Hubei Tianmen , People’s Republic of China | 867900913@qq.com | | Lilin He | First People''''s Hospital of Tianmen,Hubei Tianmen , People’s Republic of China | 372135535@qq.com |
|
| Hits: 2560 |
| Download times: 3018 |
| Abstract: |
| In recent years, immune checkpoint inhibitors have been increasingly used in clinical practice. While
considering the efficacy of immunotherapy, it is also necessary to be alert to immune-related adverse
effects (irAEs). These include skin, gastrointestinal, liver, endocrine, and pulmonary toxicities. Here, we
report a case of irAEs of hypothyroidism with marked hyperlipidemia during sintilimab administration. |
| Close |
|
|
|